United Therapeutics Corporation Defined Benefit Plan, Expected Amortization of Prior Service Cost (Credit), Next Fiscal Year
United Therapeutics Corporation (UTHR) had Defined Benefit Plan, Expected Amortization of Prior Service Cost (Credit), Next Fiscal Year of $1.30 million as of 2019-12-31, per its 10-K filed 2020-02-26.
Discontinued › Notes › Compensation Related Costs › Defined Benefit Plan
us-gaap:DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear · last filed 2020-02-26
- 2019-12-31: Defined Benefit Plan, Expected Amortization of Prior Service Cost (Credit), Next Fiscal Year $1.30M.
| Period end | Defined Benefit Plan, Expected Amortization of Prior Service Cost (Credit), Next Fiscal Year |
|---|---|
| 2019-12-31 | $1.30M 10-K · filed 2020-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |